NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...

Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Dyne Therapeutics, Inc.: Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

New analyses out to 24-months showed improvement in heart and lung function compared to expected declines in DMD natural history - - Data expand on previously reported results demonstrating that z-ros ...
What Hi-Fi?

The iconic Rega Planar 3 turntable and an Award-winning CD player are at the heart of this awesome hi-fi system

Probably the biggest evolution came a decade or so ago in 2016, but it was buffed again in 2024. The minimal but well made Planar 3 is now available in four finish options: black, white or red, all in ...
HotCars on MSN

The sports car with Lexus reliability and Porsche handling

This sports car blends Lexus level reliability with Porsche style handling, creating one of the most balanced performance ...

Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced presentations on SGT-003, its ...
Le Lézard

REGENXBIO Announces Presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

REGENXBIO Inc. today announced presentations on its RGX-202 investigational gene therapy for Duchenne muscular dystrophy at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific ...
What Hi-Fi?

This neat streaming and vinyl system is a modern take on a classic hi-fi setup – fewer boxes, great sound

That, though, is what we have here, in the form of NAD’s hugely impressive C 3050 (with MDC2 BluOS-D module) streaming ...
Santé log

Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy

Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® ...

Santhera Pharmaceuticals Holding AG: Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE (Vamorolone) within Spain's National Health System for the Treatment of ...

Pratteln, Switzerland, February 27, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE (va ...
dw

My Body, My Muscles - More Than Power and Pumping Iron

What impact does good muscle tone have on our health? Studies show that muscle training can slow down the ageing process, prevent metabolic disorders and even inhibit cancer cells. The muscular system ...